Abstract:Nucleic acid-based therapy has emerged as a revolutionary methodology for treatment of the diseases related to protein dysfunction; however, lack of systemically applicable synthetic delivery systems limits its current usage in local applications, particularly for DNA-based therapy with regard to the poor bioavailability in the systemic administrations. To overcome this obstacle, we compiled multiple chemistry-based strategies into the manufacture of the gene delivery formulations to pursue improved tolerability of DNA to the enzymatic degradation in the biological milieu and prolonged retention in the systemic circulation. Here, we constructed a distinctive multilayered functional architecture: plasmid DNA (pDNA) was electrostatically complexed with cationic poly(lysine) (polyplex) as the interior pDNA reservoir, which was further cross-linked by redox-responsive disulfide cross-linking to minimize the occurrence of polyplex disassembly through exchange reaction with the biological charged,components. Still, the pDNA reservoir was spatially protected by a sequential thermoresponsive poly(N-isopropylacrylamide) palisade as the intermediate barrier and a biocompatible hydrophilic poly(ethylene glycol) (PEG) shell with the aim of preventing the accessibility of the biological species, particularly the nuclease degradation to the pDNA payload. Subsequent investigations validated the utilities of these strategies in accomplishing prolonged blood retention. In an attempt to apply this method for tumor therapy, ligand cyclic (Arg-Gly-Asp) peptide was attached at the distal end of PEG, validating prompted tumor-targeted delivery and gene expression of the loaded antiangiogenic gene at the targeted tumor cells and accordingly exerting antiangiogenesis of the tumors for abrogation of tumor growth. Together with its excellent safe profile, the proposed formulation suggests potential utility as a practical gene delivery system for treatment of intractable diseases.

Gene therapy by virus-like self-spooling toroidal DNA condensates for revascularization of hindlimb ischemia

Highly Effective Stroke Therapy Enabled by Genetically Engineered Viral Nanofibers

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

"Molecular Bypass": The Application of vascular endothelial growth factor to gene therapy of experimental limb ischemia

A Low-Molecular-Weight Polyethylenimine/pDNA-VEGF Polyplex System Constructed in a One-Pot Manner for Hindlimb Ischemia Therapy.

Biodegradable Carriers for Delivery of VEGF Plasmid DNA for the Treatment of Critical Limb Ischemia

Peptide-based Vector of VEGF Plasmid for Efficient Gene Delivery in Vitro and Vessel Formation in Vivo.

Vascular Regeneration in Ischemic Hindlimb by Adeno‐Associated Virus Expressing Conditionally Silenced Vascular Endothelial Growth Factor

"All in one" lipid-polymer nanodelivery system for gene therapy of ischemic diseases

Highly Branched Poly(β-Amino Ester) Delivery of Minicircle DNA for Transfection of Neurodegenerative Disease Related Cells

Optimization of Adenovirus-Mediated Endothelial Nitric Oxide Synthase Delivery in Rat Hindlimb Ischemia

Intravascular Magnetic Resonance/radiofrequency May Enhance Gene Therapy for Prevention of In-Stent Neointimal Hyperplasia.

200. Factor VIII Gene Expression after Catheter-Based DNA Nanoparticle Delivery

Cell-modified Bioprinted Microspheres for Vascular Regeneration

Cell-mediated Delivery of VEGF Modified Mrna Enhances Blood Vessel Regeneration and Ameliorates Murine Critical Limb Ischemia.

Cascaded bio-responsive delivery of eNOS gene and ZNF<sub>580</sub> gene to collaboratively treat hindlimb ischemia <i>via</i> pro-angiogenesis and anti-inflammation

Enhancement of Sciatic Nerve Regeneration with Dual Delivery of Vascular Endothelial Growth Factor and Nerve Growth Factor Genes

Direct Intramuscular Injection of Psv-Vegf165 Stimulates Collateral Vessels Development in a Rabbit Model with Hindlimb Ischemia

A Biomimic Reconstituted High Density Lipoprotein Nanosystem for Enhanced VEGF Gene Therapy of Myocardial Ischemia

Synergistic Effects of FGF-2 and PDGF-BB on Angiogenesis and Muscle Regeneration in Rabbit Hindlimb Ischemia Model

Prolyl hydroxylase domain-2 silencing induced by hydrodynamic limb vein injection enhances vascular regeneration in critical limb ischemia mice through activation of multiple genes.